Home
Reels
Gruppi
Pagine
Mostra tutto
Gruppi Pagine Events Blogs Funding
Registrati Iscriviti
Night Mode
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Commenti ·0 condivisioni ·135 Views ·0 Anteprima
Effettua l'accesso per mettere mi piace, condividere e commentare!